Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html

Study Counts

Type Study_count
Total_Studies 125
interventional 91
Observational 29
Registry 5

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 42
Behavioral 11
Drug|placebo 10
Other 9
Procedure 6
Device 4
Device|placebo 2
Behavioral|Genetic 1
Behavioral|Procedure 1
Biological 1
Biological|placebo 1
Device|Drug 1
Drug|Procedure 1
Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 22
NA 14
China 7
Korea, Republic of 7
Japan 5
Canada 3
Egypt 3
Taiwan 3
United Kingdom 3
Brazil 2
Thailand 2
Argentina|Australia|Austria|Brazil|Chile|China|Czechia|Germany|Hungary|Israel|Japan|Korea, Republic of|Poland|Romania|Slovakia|Spain|United Kingdom 1
Australia|Canada 1
Australia|Germany|Italy|Netherlands|Norway|Spain|Switzerland 1
Austria 1
Austria|Bulgaria|Croatia|Czechia|France|Germany|Hungary|Italy|Moldova, Republic of|Poland|Romania|Russian Federation|Serbia|Slovakia|Spain|Sweden 1
Belgium 1
France 1
Germany 1
India 1
Italy 1
Japan|Korea, Republic of 1
Norway 1
Rwanda 1
Spain 1
Sweden 1
Turkey 1
United States|Australia|Belgium|Bulgaria|Czechia|Germany|Hungary|Israel|Italy|Latvia|Lithuania|Mexico|Poland|Puerto Rico|Romania|Spain|Taiwan|United Kingdom 1
United States|Canada|Finland|France|Hong Kong|New Zealand|Pakistan|Peru|Poland|Portugal|Russian Federation|Spain|United Kingdom 1
United States|Canada|India 1
United States|France|Poland|Portugal|Spain 1

Sites per Study

Site_count Study_Count
1 63
2 7
3 2
4 2
5 1
6 2
7 2
9 1
10 1
22 1
28 1
40 2
45 1
52 1
53 1
71 1
106 1
128 1

Phase

Phase Study_Count
N/A 35
Phase 3 27
Phase 4 13
Phase 2 11
Phase 1 2
Phase 2/Phase 3 2
Phase 1/Phase 2 1

Number of Arms

Number_of_Arms Count_of_Studies
1 26
2 50
3 5
4 2
NA 8

Enrollment Metrics by Phase

Measure N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 11.0000 10.00 15 26.00000 33.00 4.0000 14.0000
1st Qu. 47.0000 11.75 15 40.50000 63.75 55.5000 30.0000
Median 70.0000 13.50 15 73.00000 94.50 130.0000 40.0000
Mean 122.3429 13.50 15 98.27273 94.50 181.3704 115.7692
3rd Qu. 165.5000 15.25 15 93.50000 125.25 231.0000 106.0000
Max. 500.0000 17.00 15 300.00000 156.00 660.0000 518.0000

Trial Group Type

group_type Group_Count
Experimental 89
Active Comparator 30
Placebo Comparator 14
No Intervention 10
NA 8
Other 6

Intervention Model

intervention_model Study_Count
Parallel Assignment 50
Single Group Assignment 29
Crossover Assignment 9
Factorial Assignment 1
Sequential Assignment 1
NA 1

Primary Purpose

primary_purpose Study_Count
Treatment 60
Supportive Care 26
Other 2
Health Services Research 1
Prevention 1
NA 1

Observational Studies

Studies by Country

Country Study_Count
NA 5
India 3
Italy 3
Spain 3
United States 3
Taiwan 2
United Kingdom 2
Denmark 1
Denmark|Finland|France|Germany|Greece|Italy|Netherlands|Spain|Sweden|United Kingdom 1
Denmark|France|Greece|Ireland|Norway|Sweden|United Kingdom 1
France 1
Germany 1
Korea, Republic of 1
Netherlands 1
Turkey 1

Sites per Study

Site_count Study_Count
1 16
2 3
4 1
10 1
11 2
14 1
16 2
18 1
36 1
65 1

Enrollment Metrics

Measure Observational
Min 8.0000
1st Qu 75.0000
Median 118.0000
Mean 415.8966
3rd Qu 315.0000
Max 3765.0000

Observation Model

observational_model Study_Count
Cohort 15
Case-Only 7
Other 5
Case Control 1
NA 1

Time Perspective

time_perspective Study_Count
Prospective 23
Cross-Sectional 4
Retrospective 1
NA 1

Registries

Studies by Country

Country Study_Count
Thailand 2
Belgium 1
China 1
United States 1

Sites per Study

Site_count Study_Count
1 4
36 1

Enrollment Metrics

Measure Registries
Min 44.0
1st Qu 150.0
Median 164.0
Mean 327.2
3rd Qu 350.0
Max 928.0

Registry Model

observational_model Study_Count
Other 3
Cohort 1
NA 1

Time Perspective

time_perspective Study_Count
Cross-Sectional 3
Prospective 2

Follow-up

target_duration Study_Count
1 Day 1
1 Year 1
12 Weeks 1
4 Weeks 1
6 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03375515 PCA vs Non-PCA Intravenous Hydromorphone Titration for Severe Cancer Pain https://ClinicalTrials.gov/show/NCT03375515 Recruiting Fujian Cancer Hospital 2020-12-31
NCT03374592 Volumetric Intensity Modulated Arc Therapy vs. Conventional Radiotherapy for Cancer Pain https://ClinicalTrials.gov/show/NCT03374592 Completed Centre hospitalier de l’Université de Montréal (CHUM) 2017-12-20
NCT03367637 A Novel mHealth Approach to Assess and Manage Palliative Care Needs for Cancer Patients in Kigali https://ClinicalTrials.gov/show/NCT03367637 Recruiting Massachusetts General Hospital 2021-08-31
NCT00805142 Phase 2 Study of Tapentadol Prolonged Release in Cancer Pain Participants https://ClinicalTrials.gov/show/NCT00805142 Completed Janssen Pharmaceutical K.K. 2009-07-31
NCT03362073 Continuous IntraVenous Infusion of Ketamine in Terminally Ill Cancer Patients https://ClinicalTrials.gov/show/NCT03362073 Recruiting Pusan National University Yangsan Hospital 2019-12-31
NCT03338543 PENS or TENS for Pain in Liver Cancer https://ClinicalTrials.gov/show/NCT03338543 Completed Fuda Cancer Hospital, Guangzhou 2018-04-30
NCT03331055 PENS or TENS for Pain in Pancreatic Cancer https://ClinicalTrials.gov/show/NCT03331055 Completed Fuda Cancer Hospital, Guangzhou 2018-04-26
NCT03226574 Study to Evaluate Safety and MTD of Epidural Resiniferatoxin Injection for Treatment of Intractable Cancer Pain https://ClinicalTrials.gov/show/NCT03226574 Active, not recruiting Sorrento Therapeutics, Inc. 2020-03-18
NCT03205579 Pain Education to Improve Cancer Pain Management Patients https://ClinicalTrials.gov/show/NCT03205579 Recruiting Mahidol University 2019-06-30
NCT03176121 Study Evaluating Safety and Tolerability of Oxycodone in Patients With Moderate to Severe Cancer Pain https://ClinicalTrials.gov/show/NCT03176121 Completed Taiwan Mundipharma Pharmaceuticals Ltd. 2018-12-31
NCT03146806 Intranasal (NAS) Ketamine for Cancer Pain https://ClinicalTrials.gov/show/NCT03146806 Completed Emory University 2020-04-22
NCT03031938 Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies https://ClinicalTrials.gov/show/NCT03031938 Active, not recruiting Pfizer 2022-04-04
NCT02891785 Praxis Evaluation of a Pain Self-management Support Intervention for Oncology Patients: A Stepped Wedge Design Study https://ClinicalTrials.gov/show/NCT02891785 Completed University of Vienna 2018-07-31
NCT02791646 Optimizing Delivery of a Behavioral Cancer Pain Intervention Using a SMART https://ClinicalTrials.gov/show/NCT02791646 Recruiting Duke University 2021-03-31
NCT02783755 A mHealth Behavioral Cancer Pain Protocol for Medically Underserved Communities https://ClinicalTrials.gov/show/NCT02783755 Completed Duke University 2017-06-30
NCT02664350 Precision Medicine Guided Treatment for Cancer Pain https://ClinicalTrials.gov/show/NCT02664350 Completed University of Florida 2019-01-10
NCT02660229 An Interventional Study for Patient With Cancer Pain to Evaluate the Efficacy and Safety of OxyNorm® Compared to Morphine Sulfate Through the IV Continuous Infusion. https://ClinicalTrials.gov/show/NCT02660229 Completed Mundipharma Korea Ltd 2016-07-31
NCT02655289 Transcutaneous Electrical Nerve Stimulation (TENS) for Advanced Cancer Pain Patients https://ClinicalTrials.gov/show/NCT02655289 Completed University Hospital Freiburg 2018-03-31
NCT02609828 Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy. https://ClinicalTrials.gov/show/NCT02609828 Recruiting Pfizer 2020-08-11
NCT02345629 Cordotomy for Refractory Cancer Pain https://ClinicalTrials.gov/show/NCT02345629 Completed M.D. Anderson Cancer Center 2020-02-25
NCT02289261 A Comparison of Morphine and Morphine Plus Dexmedetomidine in Chronic Cancer Pain https://ClinicalTrials.gov/show/NCT02289261 Completed Cukurova University 2015-02-28
NCT02266017 Mobile Pain Coping Skills Training for Cancer Pain https://ClinicalTrials.gov/show/NCT02266017 Completed Duke University 2018-03-21
NCT01313234 Educational Intervention Targeting Nurses Attitudes and Knowledge About Cancer-related Pain Management https://ClinicalTrials.gov/show/NCT01313234 Completed Blekinge Institute of Technology 2011-06-30
NCT01968018 A Study of Safety and Effectiveness of Ultracet in Patients With Chronic Cancer Pain https://ClinicalTrials.gov/show/NCT01968018 Completed Janssen-Cilag Ltd.,Thailand 2007-04-30
NCT01906073 Nasal Fentanyl for Chronic Cancer Pain https://ClinicalTrials.gov/show/NCT01906073 Recruiting Norwegian University of Science and Technology 2020-11-30
NCT01885182 Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer Pain https://ClinicalTrials.gov/show/NCT01885182 Completed Mundipharma (China) Pharmaceutical Co. Ltd 2015-08-30
NCT01809106 RCT Comparing the Analgesic Efficacy of 4 Therapeutic Strategies Based on 4 Different Major Opioids (Fentanyl, Oxycodone, Buprenorphine vs Morphine) in Cancer Patients With Moderate/Severe Pain, at the Moment of Starting 3rd Step of WHO Analgesic Ladder. https://ClinicalTrials.gov/show/NCT01809106 Completed Mario Negri Institute for Pharmacological Research 2014-10-31
NCT01719757 PROspective Non-interventional Open laBEl Trial for TARGIN in Korean Patients With Cancer Pain https://ClinicalTrials.gov/show/NCT01719757 Completed Mundipharma Korea Ltd 2013-10-31
NCT01675622 Immediate-Release Oxycodone Capsules Study in Cancer Pain https://ClinicalTrials.gov/show/NCT01675622 Completed Mundipharma (China) Pharmaceutical Co. Ltd 2012-06-30
NCT01621100 Study to Evaluate Effectiveness and Tolerability of OROS Hydromorphone for Cancer Pain Treatment in Korean Patients https://ClinicalTrials.gov/show/NCT01621100 Completed Janssen Korea, Ltd., Korea 2012-09-30
NCT01615653 EUS Guided Celiac Neurolysis https://ClinicalTrials.gov/show/NCT01615653 Completed Mayo Clinic 2014-06-30
NCT01589328 Effect of Early Management on PAin and DEpression in Patients With PancreatoBiliary Cancer, EPADE-PB https://ClinicalTrials.gov/show/NCT01589328 Completed National Cancer Center, Korea 2017-06-30
NCT01541124 Morphine as First Drug for Cancer Pain https://ClinicalTrials.gov/show/NCT01541124 Completed Federal University of São Paulo 2011-06-30
NCT01541111 Magnesium Associated With Morphine for Cancer Pain Relief https://ClinicalTrials.gov/show/NCT01541111 Completed Federal University of São Paulo 2014-03-31
NCT01493635 Two Step Versus the Standard Three Step Approach of the WHO Analgesic Ladder for Cancer Pain Relief. https://ClinicalTrials.gov/show/NCT01493635 Completed University of Edinburgh 2016-03-31
NCT01384877 Subcutaneous Lidocaine For Cancer-Related Pain https://ClinicalTrials.gov/show/NCT01384877 Completed British Columbia Cancer Agency 2017-12-31
NCT01337089 Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain https://ClinicalTrials.gov/show/NCT01337089 Completed GW Pharmaceuticals Ltd. 2016-01-27
NCT01326689 A Comparative Study of KW-2246 https://ClinicalTrials.gov/show/NCT01326689 Completed Kyowa Kirin Co., Ltd. 2012-06-30
NCT04436705 The Effectiveness of Progressive Muscle Relaxation Technique in Reducing Cancer-related Pain https://ClinicalTrials.gov/show/NCT04436705 Completed University of Jordan 2016-09-30
NCT04162379 Oral Prednisolone Effect on Cancer WHO Stepladder Analgesia Protocol https://ClinicalTrials.gov/show/NCT04162379 Completed Mansoura University 2020-03-01
NCT04125953 Stochastic Modulated Vibrations on Autonomic Nervous System of Breast Cancer Patients During Radiotherapy https://ClinicalTrials.gov/show/NCT04125953 Recruiting Universitair Ziekenhuis Brussel 2020-09-30
NCT04095234 Integrative Medicine for Pain in Patients With Advanced Cancer Trial (IMPACT) https://ClinicalTrials.gov/show/NCT04095234 Recruiting Memorial Sloan Kettering Cancer Center 2022-09-30
NCT04085120 Ropivacaine/Dexamethasone and 10% Lignocaine Injection in GPN Block for Intractable Cancer Pain https://ClinicalTrials.gov/show/NCT04085120 Recruiting All India Institute of Medical Sciences, New Delhi 2020-01-31
NCT04040140 Integrating Auricular Point Acupressure Into Real-world Nursing Practice to Manage Cancer-related Pain https://ClinicalTrials.gov/show/NCT04040140 Recruiting Johns Hopkins University 2021-04-30
NCT03967327 A Study to Evaluate Buprenorphine Transdermal Patch in Chinese Subjects With Moderate to Severe Chronic Cancer Pain https://ClinicalTrials.gov/show/NCT03967327 Recruiting Mundipharma (China) Pharmaceutical Co. Ltd 2020-12-20
NCT03886298 Radiofrequency Splanchnic Denervation Versus Retrocrural Neurolytic Celiac Block for Pancreatic Cancer Pain https://ClinicalTrials.gov/show/NCT03886298 Recruiting Assiut University 2020-04-10
NCT03752268 Development of an Intervention to Enhance Cancer Pain Management https://ClinicalTrials.gov/show/NCT03752268 Recruiting Massachusetts General Hospital 2020-11-30
NCT03736746 Testing Feasibility of Motivational Interviewing for Patient-Reported Cancer Pain Goals https://ClinicalTrials.gov/show/NCT03736746 Completed Dana-Farber Cancer Institute 2019-08-02
NCT03669263 A Dose Titration Study of Fentanyl Buccal Soluble Film for Breakthrough Cancer Pain in Taiwan https://ClinicalTrials.gov/show/NCT03669263 Completed Chang Gung Memorial Hospital 2016-06-23
NCT03606811 Fluoroscopic &Ultrasonographic Guidance of Superior Hypogastric Plexus Neurolysis in Intractable Pelvic Pain https://ClinicalTrials.gov/show/NCT03606811 Completed Assiut University 2019-08-01
NCT03597737 Utility of an APP for the Monitoring of Irruptive Oncological Pain https://ClinicalTrials.gov/show/NCT03597737 Active, not recruiting Universitat Jaume I 2019-03-28
NCT03558594 Hypnosis and Meditation for Cancer Pain https://ClinicalTrials.gov/show/NCT03558594 Recruiting VA Puget Sound Health Care System 2020-07-28
NCT03455023 Individualized Pharmaceutical-care for Inpatients With Cancer Pain https://ClinicalTrials.gov/show/NCT03455023 Recruiting Zhejiang Cancer Hospital 2019-06-30
NCT03439904 Individualized Pharmaceutical-care in Outpatients With Cancer Pain https://ClinicalTrials.gov/show/NCT03439904 Recruiting Zhejiang Cancer Hospital 2019-06-30
NCT01165281 A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain https://ClinicalTrials.gov/show/NCT01165281 Completed Janssen Research & Development, LLC 2012-08-31
NCT01043068 The Effect of Cancer Pain Management Protocol on Hospitalized Cancer Patients: A Pilot Study https://ClinicalTrials.gov/show/NCT01043068 Completed National Cancer Center, Korea 2010-12-31
NCT00929188 A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain https://ClinicalTrials.gov/show/NCT00929188 Completed Janssen Research & Development, LLC 2015-01-31
NCT00879775 Efficacy of Caffeine Injection as an Adjuvant to Opioid Therapy in Cancer Pain https://ClinicalTrials.gov/show/NCT00879775 Completed Korea Research Foundation 2009-07-31
NCT00804076 Gene Transfer for Cancer Pain https://ClinicalTrials.gov/show/NCT00804076 Completed Diamyd Inc 2010-11-30
NCT03176199 A Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Patients With Moderate to Severe Cancer Pain https://ClinicalTrials.gov/show/NCT03176199 Completed Taiwan Mundipharma Pharmaceuticals Ltd. 2018-12-31
NCT03641222 Group Versus Individual Acupuncture for Cancer Pain https://ClinicalTrials.gov/show/NCT03641222 Completed University of Calgary 2018-08-30
NCT00771199 An Efficacy and Safety Study of Low-dose Transdermal Therapeutic System (TTS)-Fentanyl D-Trans in Taiwan Participants With Cancer Pain https://ClinicalTrials.gov/show/NCT00771199 Completed Janssen-Cilag Ltd. 2008-11-30
NCT00766831 An Efficacy and Safety Study of Hydromorphone Oral Osmotic System (OROS) in Korean Participants With Cancer Pain https://ClinicalTrials.gov/show/NCT00766831 Completed Janssen Korea, Ltd., Korea 2010-06-30
NCT00725114 Safety & Efficacy Study of Subcutaneous Tetrodotoxin for Moderate to Severe Inadequately Controlled Cancer-related Pain https://ClinicalTrials.gov/show/NCT00725114 Completed Wex Pharmaceuticals Inc. 2012-11-30
NCT00708019 Improving Cancer Pain Management Through Self-Care https://ClinicalTrials.gov/show/NCT00708019 Completed University of California, San Francisco 2012-12-31
NCT00684632 A Phase III Clinical Study of KW-2246 for Breakthrough Pain in Cancer Patients https://ClinicalTrials.gov/show/NCT00684632 Completed Kyowa Kirin Co., Ltd. 2009-04-30
NCT00683995 A Phase III Clinical Study of KW-2246 https://ClinicalTrials.gov/show/NCT00683995 Completed Kyowa Kirin Co., Ltd. 2009-07-31
NCT00676936 Corticosteroids for Cancer Pain https://ClinicalTrials.gov/show/NCT00676936 Completed Norwegian University of Science and Technology 2012-02-29
NCT00675948 Study to Compare the Safety and Tolerability of Sativex® in Patients With Cancer Related Pain https://ClinicalTrials.gov/show/NCT00675948 Completed GW Pharmaceuticals Ltd. 2006-09-30
NCT00644787 A Dose-Finding Study of Fentanyl (JNS020 QD) 1-Day Transdermal Patch in Participants With Cancer Pain https://ClinicalTrials.gov/show/NCT00644787 Completed Janssen Pharmaceutical K.K. 2008-10-31
NCT00641667 An Efficacy and Safety Study of Fentanyl (JNS020QD) in Participants With Cancer Pain https://ClinicalTrials.gov/show/NCT00641667 Completed Janssen Pharmaceutical K.K. 2008-06-30
NCT00576017 A Study to Evaluate the Safety and Effectiveness of Fentanyl-TTS Compared to Weak Opioids in Patients With Moderate to Severe Chronic Cancer Pain Previously Treated With NSAIDS (Non-steroidal Anti-inflammatory Drugs). https://ClinicalTrials.gov/show/NCT00576017 Completed Janssen-Cilag, S.A. NA
NCT00538863 Long-term Safety and Efficacy Study of Fentanyl Sublingual Spray for the Treatment of Breakthrough Cancer Pain https://ClinicalTrials.gov/show/NCT00538863 Completed INSYS Therapeutics Inc 2010-10-31
NCT00538850 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain https://ClinicalTrials.gov/show/NCT00538850 Completed INSYS Therapeutics Inc 2010-02-28
NCT00513656 A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain https://ClinicalTrials.gov/show/NCT00513656 Completed Mundipharma Research GmbH & Co KG 2010-03-31
NCT00484484 Ketamine Associated With Opioids in Refractory Cancer Pain Treatment https://ClinicalTrials.gov/show/NCT00484484 Completed Assistance Publique - Hôpitaux de Paris 2009-09-30
NCT00472303 A Study to Evaluate Tapentadol (CG5503) in the Treatment of Chronic Tumor-Related Pain Compared With Placebo and Morphine https://ClinicalTrials.gov/show/NCT00472303 Completed Grünenthal GmbH 2012-06-30
NCT00459277 Efficacy & Safety Study of Nasalfent (Fentanyl Citrate Nasal Spray) for Treatment of Breakthrough Cancer Pain in Patients Taking Regular Opioids https://ClinicalTrials.gov/show/NCT00459277 Completed Archimedes Development Ltd 2008-07-31
NCT00411034 A Repeated-Dose Evaluation of Use of a Pain Relieving Drug and Safety of OROS Hydromorphone HCI in Patients With Chronic Cancer Pain https://ClinicalTrials.gov/show/NCT00411034 Completed Alza Corporation, DE, USA NA
NCT00410787 Safety and Tolerability of Long-term Administration of OROS Hydromorphone HCI (Slow Release) in Cancer Pain https://ClinicalTrials.gov/show/NCT00410787 Completed Alza Corporation, DE, USA NA
NCT00410540 A Study of OROS Hydromorphone HCL vs Morphine in Cancer Pain Patients. https://ClinicalTrials.gov/show/NCT00410540 Completed Alza Corporation, DE, USA NA
NCT00401063 Usefulness of Acupuncture in Cancer Pain and Quality of Life https://ClinicalTrials.gov/show/NCT00401063 Completed Southern California University of Health Sciences 2007-08-31
NCT00378937 Oxycodone or Standard Pain Therapy in Treating Patients With Cancer Pain https://ClinicalTrials.gov/show/NCT00378937 Completed National Cancer Institute (NCI) NA
NCT00355628 Clinical Study of KW-2246 in Patients With Cancer Pain https://ClinicalTrials.gov/show/NCT00355628 Completed Kyowa Kirin Co., Ltd. 2007-07-31
NCT00283166 Coaching to Improve Care of Cancer Pain https://ClinicalTrials.gov/show/NCT00283166 Completed University of California, Davis 2009-03-31
NCT00279344 Efficacy and Safety of FITpatch Compared to Standard Opioid Treatment in Cancer Pain (FT-015-IN) https://ClinicalTrials.gov/show/NCT00279344 Completed Nycomed NA
NCT00216658 Phase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of Effectiveness, Safety and Pharmacokinetics - https://ClinicalTrials.gov/show/NCT00216658 Completed Janssen Pharmaceutical K.K. NA
NCT00152854 Acetaminophen for Cancer Pain https://ClinicalTrials.gov/show/NCT00152854 Completed University Health Network, Toronto 2012-12-31
NCT00136669 Acupuncture For Pancreatic Cancer Pain https://ClinicalTrials.gov/show/NCT00136669 Completed Memorial Sloan Kettering Cancer Center NA
NCT00135577 Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects https://ClinicalTrials.gov/show/NCT00135577 Completed Cubist Pharmaceuticals LLC 2007-04-30
NCT00012896 Improving Cancer Pain Management Using AHCPR Cancer Pain Guidelines https://ClinicalTrials.gov/show/NCT00012896 Completed VA Office of Research and Development NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT02899884 Characterisation and Epidemiology of Breakthrough Cancer Pain in Spain https://ClinicalTrials.gov/show/NCT02899884 Completed Takeda 2018-04-04
NCT02836379 Quality of Life Study Breakthrough Cancer Pain Treated in Radiation Oncology Services With Palliative Intent https://ClinicalTrials.gov/show/NCT02836379 Completed Angelini Farmacéutica 2017-11-30
NCT02804477 Validation and Assessment of Patient Adherence to Opioids for Cancer Pain Using MMAS 8 Pain Clinic https://ClinicalTrials.gov/show/NCT02804477 Completed Tata Memorial Centre 2016-11-30
NCT02391740 Therapeutic Patient Education and Cancer Pain https://ClinicalTrials.gov/show/NCT02391740 Completed Centre Francois Baclesse 2016-02-29
NCT02341846 Exploring New Technologies to Manage Cancer Pain in the Community https://ClinicalTrials.gov/show/NCT02341846 Completed University of Aberdeen 2015-08-31
NCT02293785 GREAT - Good Response With Appropriate Treatment https://ClinicalTrials.gov/show/NCT02293785 Completed Mario Negri Institute for Pharmacological Research 2016-02-29
NCT02151513 Pilot Study on the Effect of Intrathecal Opioids on Immune Function in Humans With Cancer Pain https://ClinicalTrials.gov/show/NCT02151513 Completed University of Utah 2018-06-01
NCT01946555 Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain https://ClinicalTrials.gov/show/NCT01946555 Completed Mario Negri Institute for Pharmacological Research 2015-12-31
NCT01816503 Fentanyl Matrix Application for Cancer Pain: Multicenter, Prospective, Observational Study https://ClinicalTrials.gov/show/NCT01816503 Completed Janssen Korea, Ltd., Korea 2009-07-31
NCT01635478 A Observational Study of Assessment and Treatment Adequacy of Emergency Cancer Pain in Tertiary Cancer Hospital https://ClinicalTrials.gov/show/NCT01635478 Completed Tata Memorial Hospital 2011-06-30
NCT01633463 An Observational Study of Pain Assessment and Treatment Adequacy of Emergency Cancer Pain https://ClinicalTrials.gov/show/NCT01633463 Completed Tata Memorial Hospital 2011-06-30
NCT01402830 Case-control Study- Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients (Fentanyl) https://ClinicalTrials.gov/show/NCT01402830 Completed Janssen-Cilag, S.A. 2008-03-31
NCT04404933 Study of Opioid-Induced Constipation 2 Project https://ClinicalTrials.gov/show/NCT04404933 Completed Royal Surrey County Hospital NHS Foundation Trust 2019-08-30
NCT04350112 Study of Opioid-Induced Constipation 1 Project https://ClinicalTrials.gov/show/NCT04350112 Completed Royal Surrey County Hospital NHS Foundation Trust 2019-08-30
NCT04315831 Safety and Effectiveness of Transdermal Buprenorphine in Cancer Pain https://ClinicalTrials.gov/show/NCT04315831 Completed Taiwan Mundipharma Pharmaceuticals Ltd. 2019-03-31
NCT04219072 Clinical Classification of Pain in Breast Cancer Survivors https://ClinicalTrials.gov/show/NCT04219072 Recruiting Kutahya Medical Sciences University 2020-08-23
NCT04053608 Human Physiology and Self-Reported Pain Score https://ClinicalTrials.gov/show/NCT04053608 Recruiting Taichung Veterans General Hospital 2020-03-14
NCT03908853 Pain Phenotyping of Patients With Bone Cancer Pain https://ClinicalTrials.gov/show/NCT03908853 Recruiting University of Copenhagen 2021-04-01
NCT03638440 Real World Observational Study of Naloxegol for Patients With Cancer Pain Diagnosed With OIC. https://ClinicalTrials.gov/show/NCT03638440 Recruiting Kyowa Kirin Pharmaceutical Development Ltd 2019-11-30
NCT03550599 Adequacy of Pain Treatment in Radiotherapy https://ClinicalTrials.gov/show/NCT03550599 Recruiting Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi 2019-03-01
NCT03546023 Brief Pain Inventory to Assess Cancer Pain and Quality of Life https://ClinicalTrials.gov/show/NCT03546023 Completed Tata Memorial Hospital 2019-06-04
NCT03435120 Quality of Life Study Breakthrough Cancer Pain Treated in Medical Oncology Services (CAVIDIOM) https://ClinicalTrials.gov/show/NCT03435120 Completed Angelini Farmacéutica 2020-01-24
NCT01230515 Opioid Titration in the Hospice Setting: Barriers Assessment and Modification of the Model Order Sheet and Protocol https://ClinicalTrials.gov/show/NCT01230515 Completed Vanderbilt-Ingram Cancer Center 2007-11-30
NCT01045603 Instanyl® Non-Interventional Study https://ClinicalTrials.gov/show/NCT01045603 Completed Takeda 2012-04-30
NCT00956878 Cancer Pain Single Nucleotide Polymorphisms (SNPs) https://ClinicalTrials.gov/show/NCT00956878 Completed Erasmus Medical Center 2012-12-31
NCT03895762 Observational Study of Efficacy, Safety and Tolerability of Fentanyl in Korean Cancer Patients https://ClinicalTrials.gov/show/NCT03895762 Recruiting A.Menarini Asia-Pacific Holdings Pte Ltd 2019-05-15
NCT03727373 Qualitative Study for Pain Measurement Using Innovative Health Technology https://ClinicalTrials.gov/show/NCT03727373 Completed University of Schleswig-Holstein 2018-11-23
NCT01829828 The Effectiveness of a Patient Self-reported Pain Scoring Tool and a Satisfaction Survey on Cancer Pain Management https://ClinicalTrials.gov/show/NCT01829828 Completed Janssen Korea, Ltd., Korea 2012-05-31
NCT00507351 Ambulatory Cancer Pain Management: A Feasibility Study https://ClinicalTrials.gov/show/NCT00507351 Completed M.D. Anderson Cancer Center 2009-07-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT01936636 Observational Registry Study of Quality of Life When Treating BTcP With Abstral https://ClinicalTrials.gov/show/NCT01936636 Completed Galena Biopharma, Inc. 2015-06-30
NCT03981809 Screening Tool to Identify the Dominant Pain Mechanism in Cancer Survivors: PainsCan https://ClinicalTrials.gov/show/NCT03981809 Recruiting Universitaire Ziekenhuizen Leuven 2020-11-16
NCT03686605 The Edmonton Symptom Assessment System (ESAS) as a Screening Tool for Depression in Cancer Pain Patients https://ClinicalTrials.gov/show/NCT03686605 Enrolling by invitation Mahidol University 2019-07-08
NCT03641820 Cognitive Dysfunction in Patients With Cancer Pain https://ClinicalTrials.gov/show/NCT03641820 Recruiting Fujian Cancer Hospital 2019-02-28
NCT03474406 The Effectiveness of Cancer Pain Management in Siriraj Outpatient Pain Clinic https://ClinicalTrials.gov/show/NCT03474406 Recruiting Mahidol University 2019-03-30